MA42186B1 - Antigen binding proteins that activate the leptin receptor - Google Patents

Antigen binding proteins that activate the leptin receptor

Info

Publication number
MA42186B1
MA42186B1 MA42186A MA42186A MA42186B1 MA 42186 B1 MA42186 B1 MA 42186B1 MA 42186 A MA42186 A MA 42186A MA 42186 A MA42186 A MA 42186A MA 42186 B1 MA42186 B1 MA 42186B1
Authority
MA
Morocco
Prior art keywords
antigen binding
antibodies
activate
leptin receptor
binding proteins
Prior art date
Application number
MA42186A
Other languages
French (fr)
Other versions
MA42186A1 (en
Inventor
Jesper Gromada
Panayiotis Stevis
Judith ALTAREJOS
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2016/056465 external-priority patent/WO2017066204A1/en
Publication of MA42186A1 publication Critical patent/MA42186A1/en
Publication of MA42186B1 publication Critical patent/MA42186B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des anticorps et des fragments de liaison d'antigène d'anticorps qui se lient au récepteur de la leptine (lepr), et des procédés d'utilisation de ces derniers. Selon certains modes de réalisation, l'invention concerne des anticorps et des fragments de liaison d'antigène d'anticorps qui se lient à la lepr et activent la signalisation par la lepr. Selon d'autres modes de réalisation, l'invention concerne des anticorps et des fragments de liaison d'antigène d'anticorps qui se lThe present invention provides antibodies and antigen binding fragments of antibodies that bind to the leptin receptor (lepr), and methods of using the same. According to certain embodiments, the invention relates to antibodies and antigen binding fragments of antibodies that bind to lepr and activate lepr signaling. According to other embodiments, the invention relates to antibodies and antigen binding fragments of antibodies which bind

MA42186A 2015-10-12 2016-10-11 Antigen binding proteins that activate the leptin receptor MA42186B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562240021P 2015-10-12 2015-10-12
PCT/US2016/056465 WO2017066204A1 (en) 2015-10-12 2016-10-11 Antigen-binding proteins that activate the leptin receptor

Publications (2)

Publication Number Publication Date
MA42186A1 MA42186A1 (en) 2018-07-31
MA42186B1 true MA42186B1 (en) 2019-08-30

Family

ID=61158540

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42186A MA42186B1 (en) 2015-10-12 2016-10-11 Antigen binding proteins that activate the leptin receptor

Country Status (2)

Country Link
AR (2) AR106319A1 (en)
MA (1) MA42186B1 (en)

Also Published As

Publication number Publication date
AR115992A2 (en) 2021-03-17
MA42186A1 (en) 2018-07-31
AR106319A1 (en) 2018-01-03

Similar Documents

Publication Publication Date Title
PH12018502601A1 (en) Anti-b7-h3 antibodies and antibody drug conjugates
MX2021003393A (en) Sirpî± binding proteins and methods of use thereof.
MA40801A1 (en) Anti-cd3 antibody, anti-cd123 antibody and bispecific antibodies binding specifically to cd3 and / or cd123
MX2018016265A (en) Heterodimeric antibodies that bind somatostatin receptor 2.
PH12021550337A1 (en) Anti-gdf15 antibodies, compositions and methods of use
WO2019224718A3 (en) Psma binding agents and uses thereof
CL2023000896A1 (en) Chimeric dll3 receptors and methods for their use
MA34287B1 (en) COMPOSITIONS AND METHODS OF USING LOW DENSITY THERAPEUTIC MULTIVALENT ANTIBODIES OF LIPOPROTEIN 6-RELATED PROTEIN (LRP6)
PH12018501882A1 (en) Binding proteins and methods of use thereof
MA38498A1 (en) Anti-lag-3 binding proteins
MA40609B1 (en) Cd123 binding agents and their uses
MA43186B1 (en) Antibodies specifically binding to pd-1 and uses thereof
EA201891582A1 (en) IMMUNOSMULATING HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEYKIN-2 AND THEIR FUSED PROTEINS
MX2018015277A (en) Anti-b7-h3 antibodies and antibody drug conjugates.
MX2018015285A (en) Anti-b7-h3 antibodies and antibody drug conjugates.
BR112018003326A2 (en) thymic stromal lymphopoietin (tslp) binding antibodies and methods of use of antibodies
EA201100300A1 (en) COMPOSITIONS AND METHODS INTENDED FOR THE DIRECTED IMPACT OF ANTIBODIES ON C5 COMPLEMENT SYSTEM
MA39061A1 (en) Aplnr modulators and their uses
EA201791691A1 (en) SINGLE-DOMAIN ANTIBODIES DIRECTED TO CD1d
MX2018013072A (en) Tl1a antibodies and uses thereof.
EA202092508A1 (en) COMPOSITIONS BASED ON ANTIBODIES TO HUMAN PD-L1
BR112021023540A2 (en) affinity agents
CL2020002597A1 (en) Methods for preparing stable protein compositions
MX2021007589A (en) Anti-il-36 antibodies and methods of use thereof.
MA39090A1 (en) Anti-ccl17 Antibody